C07K 16/1239
From vibrionaceae
Official title: {from Vibrionaceae (G)}
C07K16/1239 (From vibrionaceae) appears on 32 US grants and 62 published applications in this corpus.
Search patents in C07K- Granted patents
- 32
- Published applications
- 62
- Assignees
- 18
- Inventors
- 44
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 4 |
| 2013 | 0 | 4 |
| 2014 | 1 | 9 |
| 2015 | 1 | 7 |
| 2016 | 8 | 7 |
| 2017 | 1 | 12 |
| 2018 | 5 | 1 |
| 2019 | 2 | 1 |
| 2020 | 1 | 5 |
| 2021 | 0 | 1 |
| 2022 | 1 | 2 |
| 2023 | 3 | 4 |
| 2024 | 0 | 2 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ostrich antibody for bacterial infectious diseases3 Mar 2026US 12,564,624 B2Ostrich Pharma KK
- Animal models and therapeutic molecules14 Nov 2023US 11,812,731 B2Kymab Limited
- Animal models and therapeutic molecules21 Mar 2023US 11,606,941 B2Kymab Limited
- Animal models and therapeutic molecules31 Jan 2023US 11,564,380 B2Kymab Limited
- Animal models and therapeutic molecules12 Apr 2022US 11,297,810 B2Kymab Limited
- Ostrich antibody for bacterial infectious diseases10 Oct 2024US 2024/0335519 A1Ostrich Pharma KK
- Animal Models and Therapeutic Molecules22 Feb 2024US 2024/0057572 A1Kymab Limited
- Animal Models and Therapeutic Molecules31 Aug 2023US 2023/0270088 A1Kymab Limited
- Animal Models and Therapeutic Molecules24 Aug 2023US 2023/0263143 A1Kymab Limited
- Animal Models and Therapeutic Molecules20 Jul 2023US 2023/0225302 A1Kymab Limited
Most cited
By later US patents
- Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers48US 4,808,700 APraxis Biologics, Inc. · 1989
- Animal models and therapeutic molecules47US 9,445,581 B2Kymab Limited · 2016
- Animal models and therapeutic molecules30US 9,253,965 B2Kymab Limited · 2016
- Animal models and therapeutic molecules28US 9,504,236 B2Kymab Limited · 2016
- Animal models and therapeutic molecules27US 9,434,782 B2Kymab Limited · 2016